Evidence map›Paper›PMID 38736006›Full record

SynthesisNeurosurgical review2024

Feasibility, safety, and efficacy of endovascular treatment of anterior cranial fossa dural arteriovenous fistulas: a systematic review and meta-analysis with a subanalysis for Onyx.

Marcio Yuri Ferreira, Ahmet Gunkan, Savio Batista, Mauricio Porto, Raphael Camerotte, Leonardo de Barros Oliveira, Silvio Porto Junior, Obiora Okoye, Igor Oliveira da Fonseca, Raphael Bertani and 5 more

Abstract readSystematic ReviewMeta-Analysis
PubMed Publisher
In one paragraph

Synthesis in Neurosurgical review, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marcio Yuri FerreiraFaculty of Medicine, Ninth July University, São Paulo, SP, Brazil.
Ahmet GunkanDepartment of Radiology, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey. gunkanahmet@gmail.com.ORCID http://orcid.org/0000-0002-6236-5633
Savio BatistaFaculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Mauricio PortoFaculty of Medicine, Salvador University, Salvador, Bahia, Brazil.
Raphael CamerotteFaculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Leonardo de Barros OliveiraState University of Ponta Grossa, Ponta Grossa, PR, Brazil.
Silvio Porto JuniorBahiana School of Medicine and Public Health, Salvador, BA, Brazil.
Obiora OkoyeSub-Saharan Africa Brain Health Initiative (SSABHI), Abuja, Nigeria.
Igor Oliveira da FonsecaClinical Hospital of São Paulo State University, São Paulo, SP, Brazil.
Raphael BertaniDepartment of Neurosurgery, University of São Paulo, São Paulo, SP, Brazil.
Elias Antonio Tanus MachadoDepartment of Endovascular Neurosurgery, Paulo Niemeyer State Brain Institute, Rio de Janeiro, RJ, Brazil.
Christian FerreiraDepartment of Neurosurgery, Lenox Hill Hospital, New York, NY, USA.
David LangerDepartment of Neurosurgery, Lenox Hill Hospital, New York, NY, USA.
Gabriele CiccioDepartment of Radiology, CHU de Saint Etienne, Saint Etienne, France.
Yafell SerulleDepartment of Neurosurgery, Lenox Hill Hospital, New York, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dural Arteriovenous Fistulas (dAVFs) of the anterior cranial fossa (ACF) are uncommon but carry a high risk of hemorrhage and pose substantial treatment challenges. Recent advancements in endovascular treatment (EVT), including the introduction of novel liquid embolic agents, have markedly bolstered EVT's role in managing ACF-dAVFs, with notable series published in the last five years. We aimed to assess the feasibility, safety, and efficacy of EVT for ACF-dAVFs. We searched Medline, Scopus, Web of Science, and Cochrane Library databases following PRISMA guidelines. Eligible studies included those with ≥ 5 patients undergoing embolization of ACF-dAVFs, detailing both angiographic and clinical outcomes. We used single proportion analysis with 95% confidence intervals under a random-effects model, I

Indexed as

Central Nervous System Vascular MalformationsCranial Fossa, AnteriorEmbolization, TherapeuticEndovascular ProceduresPolyvinylsDimethyl SulfoxideFeasibility StudiesHumansTreatment OutcomeDimethyl SulfoxideOnyx copolymerPolyvinylsAnterior cranial fossaDural arteriovenous fistulaEmbolizationEndovascularEthmoidalOnyx

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.